LexDanaLexDanabeta
Inventor

Chandra Vargeese

Inventor
Schwenksville, PA, US

Overview

44→
Patents
1991–2021
Patent span
Chemistry
Primary field (CPC C)

Patents· 44 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C12Nprimary
C12NMicroorganisms or enzymes24%
A61KPreparations for medical, dental or toiletry purposes15%
C07HSugars15%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations9%
C12YEnzymes8%
C07CAcyclic or carbocyclic compounds6%
C07JSteroids4%
C07DHeterocyclic compounds3%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%
C07KPeptides3%
PatentTitleYear
11,013,757Oligonucleotides, compositions and methods thereof202110,889,815RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)202110,792,361Lipids and lipid compositions for the delivery of active agents202010,729,775Lipids and lipid compositions for the delivery of active agents202010,724,035Oligonucleotide compositions and methods thereof202010,662,428RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)202010,479,995Oligonucleotide compositions and methods thereof201910,450,568Oligonucleotide compositions and methods thereof201910,351,852RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)201910,342,761Method of encapsulating a nucleic acid in a lipid nanoparticle host201910,329,563Organic compositions to treat HSF1-related diseases201910,124,065Lipids and lipid compositions for the delivery of active agents201810,000,754RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)20189,957,517RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)20189,771,588'RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)'20179,738,899'RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)'20179,732,344'RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)'20179,657,294'RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)'20179,504,747'Lipids and lipid compositions for the delivery of active agents'20169,301,923'Lipids, lipid compositions, and methods of using them'20169,181,551'RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)'20158,846,894'RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)'20147,964,578'Conjugates and compositions for cellular delivery'20117,935,812'RNA interference mediated inhibition of hepatitis C virus (HCV) expression using short interfering nucleic acid (siNA)'20117,893,249'Deprotection and purification of oligonucleotides and their derivatives'20117,893,302'Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules'20117,833,992'Conjugates and compositions for cellular delivery'20107,777,023'Method for the chemical synthesis of oligonucleotides'20107,691,405'Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules'20107,655,790'Deprotection and purification of oligonucleotides and their derivatives'20107,641,915'Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules'20107,517,864'RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)'20097,514,099'Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules'20097,491,805'Conjugates and compositions for cellular delivery'20097,404,969'Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules'20087,205,399'Methods and reagents for oligonucleotide synthesis'20076,995,259'Method for the chemical synthesis of oligonucleotides'20066,989,442'Deprotection and purification of oligonucleotides and their derivatives'20066,962,784'Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes'20056,426,335'Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes'20026,168,778'Vascular endothelial growth factor (VEGF) Nucleic Acid Ligand Complexes'20016,051,698'Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes'20006,020,206'Homocysteine assay'20005,077,403'Process to prepare pyrimidine nucleosides'1991

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2000–2007Based in Thornton, CO, US· patent location history
2002–2005Patents assigned to GILEAD SCIENCES INC (2)· patent assignee history
2006–2021Patents assigned to SIRNA THERAPEUTICS INC (25)· patent assignee history
2008–2021Based in Schwenksville, PA, US· patent location history
2009–2014Based in Broomfield, CO, US· patent location history
2010Based in Blue Bell, PA, US· patent location history
2016–2020Patents assigned to NOVARTIS AG (6)· patent assignee history
2016Patents assigned to BOWMAN KEITH (2)· patent assignee history
2016–2020Based in Cambridge, MA, US· patent location history
2019–2021Patents assigned to WAVE LIFE SCIENCES LTD (4)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
SIRNA THERAPEUTICS INC252006–2021
NOVARTIS AG62016–2020
WAVE LIFE SCIENCES LTD42019–2021
BOWMAN KEITH22016
GILEAD SCIENCES INC22002–2005
Locations
LocationPatentsSpan
Schwenksville, Pennsylvania, US232008–2021
Broomfield, CO, US82009–2014
Thornton, CO, US82000–2007
Cambridge, Massachusetts, US32016–2020
Blue Bell, Pennsylvania, US12010